Addex Therapeutics (ADXN) Non Operating Income (2022 - 2025)
Historic Non Operating Income for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to -$1021.3.
- Addex Therapeutics' Non Operating Income rose 9709.31% to -$1021.3 in Q3 2025 from the same period last year, while for Sep 2025 it was $15851.6, marking a year-over-year increase of 10539.61%. This contributed to the annual value of $26198.7 for FY2024, which is 10914.88% up from last year.
- Addex Therapeutics' Non Operating Income amounted to -$1021.3 in Q3 2025, which was up 9709.31% from $7043.2 recorded in Q2 2025.
- In the past 5 years, Addex Therapeutics' Non Operating Income registered a high of $61440.9 during Q3 2022, and its lowest value of -$294798.2 during Q4 2022.
- In the last 4 years, Addex Therapeutics' Non Operating Income had a median value of -$21299.6 in 2025 and averaged -$53978.2.
- Within the past 5 years, the most significant YoY rise in Addex Therapeutics' Non Operating Income was 248298.83% (2024), while the steepest drop was 18060.1% (2024).
- Over the past 4 years, Addex Therapeutics' Non Operating Income (Quarter) stood at -$294798.2 in 2022, then grew by 1.72% to -$289730.1 in 2023, then skyrocketed by 110.74% to $31129.3 in 2024, then tumbled by 103.28% to -$1021.3 in 2025.
- Its last three reported values are -$1021.3 in Q3 2025, $7043.2 for Q2 2025, and -$21299.6 during Q1 2025.